Germany: Eurofins strengthens dermatology drug testing with acquisition of bioskin

In line with its strategy to expand its position in cosmetics and personal care and to diversify its clinical testing footprint in dermatology, for medicinal products and medical devices, Eurofins, the Luxembourg-based laboratory group, has acquired bioskin, a German full-service, dermatology-specific CRO specialising in trials for drugs, medical devices, food supplements and advanced cosmetics. Established…

You must be a HMI Subscriber to view this content.

Subscribe Now »